Calotron Syrup contains Calcium Polystyrene Sulphonate 15 gm, a clinically proven potassium-binding resin indicated for the management of hyperkalemia. It helps in lowering elevated serum potassium levels, especially in patients with renal insufficiency, chronic kidney disease, and metabolic imbalances.
Calcium Polystyrene Sulphonate works by exchanging calcium ions for potassium ions in the gastrointestinal tract, facilitating the removal of excess potassium through fecal excretion. This mechanism supports electrolyte balance and helps prevent complications associated with high potassium levels.
For distributors and healthcare suppliers, Calotron Syrup is a high-demand renal care product, widely used in hospitals, nephrology clinics, dialysis centers, and critical care settings. The increasing prevalence of kidney disorders and electrolyte imbalance conditions ensures consistent and recurring demand.
Adding Calotron Syrup to your renal care and electrolyte management segment creates strong opportunities in pharmacies, hospitals, specialty clinics, export markets, and third-party manufacturing. Its established clinical role, reliable efficacy, and wide therapeutic application make it a valuable addition to pharmaceutical distribution portfolios.